In the UK, the same Wegovy pen can cost £9.90 on the NHS in England but £150–£300 per month privately, depending on dose, and the 2026 launch of the Wegovy tablet adds a roughly £69–£269 monthly range to consider.

That difference is why the cost of Wegovy can't be answered with one figure. The amount you pay depends on who funds the prescription, where you live, which strength you use, how the dose changes, and what a private provider includes in its fee. A person in Cardiff may face no NHS prescription charge, while someone in London may pay the standard English charge if they qualify for NHS treatment, or a private monthly fee if they don't.

This guide separates the medicine's official list prices from real-world patient costs. It also explains the evidence behind dose escalation, the restricted NHS pathway under NICE, the emerging tablet market, and the practical questions to ask before committing to treatment.

Table of Contents

• Why Wegovy Costs Vary So Much Across the UK
• How Wegovy Works and Why Dose Matters for Price
  • Why a higher dose changes the bill
• Wegovy Dose Escalation and Monthly Private Prices
  • How the four-week pack works
• NHS vs Private Access and What You Actually Pay
• Comparing Wegovy With Mounjaro and Orlistat
• Total Treatment Cost Over 6 and 12 Months
• Practical Ways to Manage the Cost of Wegovy
  • Build a complete price comparison
• Key Takeaways Before You Start Wegovy
  • Questions to discuss with a clinician

Why Wegovy Costs Vary So Much Across the UK

Two adults requesting Wegovy on the same day can receive different prices. One may be assessed through an NHS specialist weight-management service; another may use an online clinic, high-street pharmacy, or private prescriber. The dose strength also matters, so a starter pen and a maintenance pen may not cost the same.

In England, the NHS route follows NICE technology appraisal TA875. Eligible adults pay the standard NHS prescription charge, while prescription charges in Scotland, Wales, and Northern Ireland follow devolved rules. Treatment is provided through a specialist service rather than as a routine GP purchase. NICE recommends a maximum NHS treatment period of 2 years, subject to clinical decisions and local implementation. The eligibility criteria appear in the NICE recommendation for semaglutide.

Private treatment has a different pricing structure. A provider may quote one combined fee covering the pen, clinical assessment, dispensing, delivery, monitoring, or membership support, while another may charge for these separately. This makes headline monthly prices difficult to compare. Dose escalation can also shift the cost from a lower-priced starter strength to a more expensive maintenance strength.

The projected 2026 tablet launch introduces another possible cost. UK reporting gives a private monthly range of approximately £69 to £269, depending on strength and provider. Reported starting and maximum prices vary between sources, so the quoted price needs checking before treatment begins.

An overview of online weight-loss medication can help distinguish clinical assessment, prescription supply, and unregulated sellers. Calculating the full cost across dose escalation gives a more realistic picture than comparing one advertised monthly figure.

How Wegovy Works and Why Dose Matters for Price

Wegovy contains semaglutide, a GLP-1 receptor agonist used alongside diet and physical activity for weight management. In simple terms, it imitates a naturally occurring gut hormone involved in appetite regulation. It can increase feelings of fullness, influence hunger signals in the brain, and slow the movement of food through the stomach.

The medicine is given as a once-weekly subcutaneous injection. Patients don't usually begin at the highest strength. Instead, clinicians increase the dose gradually to help the body adjust and to manage adverse effects such as nausea or other gastrointestinal symptoms.

The standard strengths relevant to UK pricing are 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg. The first four steps are generally used during escalation, while 1.7 mg or 2.4 mg may be used as maintenance, depending on clinical response and tolerability. NICE's product information describes gradual escalation over approximately 16 weeks, although clinicians may adjust the pace for an individual patient NICE semaglutide information.

Why a higher dose changes the bill

Each strength is supplied as a separate pre-filled pen pack. A patient moving from 0.5 mg to 1.0 mg is receiving more medicine in a different box. The pharmacy supplies the new strength, so private treatment costs can change at each escalation point.

The clinical evidence also needs to be interpreted correctly. The STEP 5 programme was a phase 3b randomised, double-blind, placebo-controlled study involving 304 adults with obesity without type 2 diabetes. Participants used semaglutide 2.4 mg alongside lifestyle support, including a 500 kcal/day reduced diet and 150 minutes of weekly physical activity, as described in the trial report STEP 5 background and results. That design supports an important practical point: the medicine was studied as part of a structured treatment plan, not as a substitute for nutrition, movement, or clinical follow-up.

Wegovy Dose Escalation and Monthly Private Prices

A Wegovy pack usually covers one treatment month, but the monthly bill can rise as the dose increases. NICE's historical UK figures help explain why there is no single price for every patient. They exclude VAT and reflect the company's official list pricing recorded in March 2023, rather than the final amount charged privately. Consultation, dispensing, delivery, monitoring, and pharmacy margins may be added.

The pack prices appear in the NICE semaglutide pricing information. Private prices vary because a provider may include prescribing, clinical review, delivery, or monitoring. Published comparisons also show a wide range, from approximately £79 to £219, so check whether a quoted price applies to the prescribed strength and whether clinical services are included UK Wegovy price comparison.

How the four-week pack works

Each pack contains four weekly doses, covering a 28-day period in ordinary use. In simple terms, one pack is usually one treatment month. The calculation changes during dose escalation because the prescriber may issue a different strength before the previous pack would otherwise have been reordered.

This matters when estimating the cost of the full journey. A lower introductory price does not necessarily represent the later maintenance cost, and the table's ranges should be read as dose-specific rather than as a guaranteed monthly schedule.

The 2026 tablet market adds another comparison. Reports describe private tablet prices from roughly £69 per month at a lower dose to about £189 at the highest dose, while other coverage cites approximately £99 to £149 initially and up to £269 at the top dose The Guardian's report on UK tablet pricing. The different figures reflect variation in dose, supplier, and included services, so a starting price should not be used as the expected long-term cost.

Pricing rule: Compare the full price for the prescribed strength, not the cheapest introductory figure shown on a clinic homepage.

NHS vs Private Access and What You Actually Pay

The most important cost question is whether you're eligible for NHS treatment. Under NICE TA875, Wegovy can be prescribed for adults with at least one weight-related comorbidity and either a BMI of at least 35.0 kg/m², or a BMI of 30.0 to 34.9 kg/m² where referral criteria for specialist overweight and obesity services are met. Treatment must take place within a specialist multidisciplinary weight-management service, with a maximum treatment duration of 2 years NICE guidance for managing overweight and obesity.

In England, a 12-month Prescription Prepayment Certificate costs £114.50, which may reduce the cost for someone collecting regular NHS prescriptions NHS and private Wegovy costs in the UK. Prescription rules are different in the devolved nations, where NHS prescriptions are free at the point of use.

Private supply may come through an online clinic, an in-person specialist, a pharmacy-led service, or a face-to-face GP arrangement. The quoted amount can include a clinical consultation, the pen, dispensing, delivery, and follow-up, but not every provider includes all of these. A practical guide to how to get Wegovy explains the assessment and supply process without treating private access as automatic.

NHS eligibility isn't the same as a general right to request Wegovy from any GP. The specialist pathway determines whether treatment is appropriate and available.

Comparing Wegovy With Mounjaro and Orlistat

Cost is meaningful only when the medicines being compared have similar aims but different clinical profiles. Mounjaro contains tirzepatide, which acts on both GIP and GLP-1 pathways. Wegovy acts on the GLP-1 pathway. Both are prescription medicines, so treatment involves clinical assessment, dose adjustment, and monitoring rather than choosing the cheapest monthly price.

Private Mounjaro prices vary by strength and provider, as Wegovy prices do. Clinical trial programmes for tirzepatide have generally reported greater average weight loss than the semaglutide results reported in STEP studies. The studies did not use identical populations, doses, treatment protocols, or follow-up periods, so their headline results cannot be treated as a direct price or effectiveness ranking. Medical history, side effects, contraindications, availability, and individual suitability also affect the choice. A fuller comparison is available in this guide to Wegovy or Mounjaro in the UK.

Orlistat works differently. It reduces the absorption of dietary fat in the gut instead of changing appetite signalling through a GLP-1 pathway. Generic orlistat is usually much cheaper than injectable treatments, although its expected weight-loss effect is more modest. Gastrointestinal side effects can also affect whether treatment is continued.

In England, an eligible NHS prescription costs £9.90 per item, including prescribed orlistat. The clinician and relevant NHS pathway still determine whether it is suitable. A lower medicine price does not make orlistat the right option for everyone, while a higher injectable cost does not establish that Wegovy or Mounjaro is clinically appropriate. Comparing the full treatment journey, including dose changes and monitoring, gives a more useful picture than comparing one monthly price.

Total Treatment Cost Over 6 and 12 Months

A realistic budget should include the escalation period rather than multiplying the highest dose by every month. During the approximately 16-week titration schedule, a patient may pass through 0.25 mg, 0.5 mg, 1.0 mg, and 1.7 mg before reaching a maintenance decision. The exact pattern depends on tolerability and clinical response, so a forecast is an estimate, not a prescription plan.

Private six-month journeys are often described in the broad region of £1,400 to £1,800, while a 12-month course may fall around £2,400 to £3,000 once maintenance treatment accounts for most of the year. These totals can include different provider prices and may exclude or include consultations, delivery, and monitoring, so ask for an itemised quote before comparing clinics.

NICE also provides a stopping rule. Semaglutide should be considered for discontinuation if the patient has lost less than 5% of initial body weight after 6 months of treatment, linking continuation to measurable response NICE patient-facing recommendations. That rule matters financially as well as clinically, because it discourages assuming that every patient will continue indefinitely.

Private clinic consultation fees may add approximately £20 to £60 per visit, depending on the service. The tablet's reported private range of approximately £69 to £269 per month may alter the budget for some patients, but switching format still requires a clinician's assessment.

A responsible budget includes the medicine, consultations, dispensing, delivery, monitoring, and the possibility that treatment may stop if it isn't effective or tolerated.

Practical Ways to Manage the Cost of Wegovy

Check whether you may qualify for NHS treatment before paying privately. In England, an eligible NHS prescription may involve the standard prescription charge rather than the private medicine price. Prescriptions are free at the point of use in Scotland, Wales, and Northern Ireland, although eligibility and local access rules still apply.

Build a complete price comparison

Use the same checklist with every provider. A low monthly figure may cover only the medicine, rather than the clinical service around it.

• Medicine: Confirm the exact strength and whether the quote covers one four-week pack.
• Clinical care: Ask whether the initial assessment, follow-up reviews, and dose decisions are included.
• Dispensing and delivery: Check for separate pharmacy, delivery, or membership charges.
• Monitoring: Ask how the service handles side effects, missed doses, and treatment changes.
• Regulation: Verify that the prescriber and dispensing pharmacy are authorised to provide the service.

For regular NHS prescriptions in England, a 12-month Prescription Prepayment Certificate costs £114.50. It can reduce prescription-charge costs for eligible NHS prescriptions, but it does not make private Wegovy free or remove the need to qualify for NHS treatment.

Avoid sellers on social media or websites that do not provide a proper clinical assessment. A lower price cannot compensate for uncertain storage, authenticity, dosing instructions, or no follow-up. Ask a clinician about the tablet when it becomes available through an appropriate UK route. A lower advertised starting price is not, by itself, a reason to change treatment format.

Trim is one example of a UK online clinic and pharmacy describing medically supervised Wegovy and Mounjaro supply, clinician assessment, delivery, support, and lifestyle guidance through its weight-management service. Compare what each regulated provider includes, rather than comparing medicine prices alone.

Key Takeaways Before You Start Wegovy

Wegovy is better understood as a clinically monitored treatment plan than as a permanent monthly purchase. The cost can change as the dose rises, and long-term affordability depends on whether treatment is funded through the NHS, paid for privately, or changed to the tablet format.

NHS access is restricted. In England, qualifying patients use a specialist pathway and pay the standard prescription charge, while devolved-nation rules mean NHS prescriptions are free at the point of use in Scotland, Wales, and Northern Ireland. Private treatment generally costs much more, with monthly prices commonly shaped by dose, provider fees, dispensing, delivery, and follow-up.

The 2026 tablet launch creates another option to discuss, but reported prices vary substantially by strength and provider. Before paying, confirm that the prescriber is GMC-registered and the pharmacy is GPhC-registered. Ask for the total price, not just the first month's figure.

Questions to discuss with a clinician

• Suitability: Does my medical history make semaglutide appropriate?
• Dose plan: How will escalation be adjusted if I experience side effects?
• Response: What will happen if I don't meet the NICE stopping threshold?
• Duration: What is the expected treatment period, and what could happen after stopping?
• Lifestyle support: What nutrition, activity, and strength-training support will accompany the medicine?
• Budget: What will I pay for the pen, consultations, dispensing, delivery, and monitoring?

Weight regain can occur after treatment stops, so discuss maintenance and follow-up before starting rather than treating discontinuation as an afterthought. The safest decision is the one that fits your clinical needs, local access rules, expected duration, and actual budget.

Trim provides medically supervised weight-management assessments, regulated prescription supply, clinical support, and lifestyle guidance for people comparing options such as Wegovy, Mounjaro, and orlistat. Visit Trim to review the service and complete an assessment if you want to discuss suitable treatment with a UK-registered clinician.